Autoimmune glial fibrillary acidic protein astrocytopathy presented as isolated area postrema symdrome: a case report

BMC Neurol. 2022 Jul 20;22(1):271. doi: 10.1186/s12883-022-02802-2.

Abstract

Background: Area postrema syndrome (APS) as the isolated manifestation in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy has been rarely reported.

Case presentation: A 61-year-old male patient presented with intractable hiccup. He was first admitted to the department of Gastroenterology because he had no symptoms other than hiccup. Then he was diagnosed with possible digestive system disease and started on treatment. 2 weeks later, his symptom didn't improve at all. After consultation, the patient was referred to our department. Cerebrospinal fluid (CSF) analysis revealed lymphocytes pleocytosis, elevated protein level. Cell-based assays demonstrated GFAP antibodies in blood and CSF. His symptom improved with steroid pulse therapy (methylprednisolone, 1 g for 5 days), followed by a gradual tapering of oral prednisolone. Three months after the initial presentation, he showed no relapses.

Conclusions: We report atypical manifestation of autoimmune GFAP astrocytopathy which presented as APS, suggesting that autoimmune GFAP astrocytopathy should be added to the list of possible cause of APS.

Keywords: Area postrema symdrome; Autoimmune; Encephalitis; GFAP; Hiccup.

Publication types

  • Case Reports

MeSH terms

  • Area Postrema*
  • Astrocytes
  • Glial Fibrillary Acidic Protein
  • Hiccup* / etiology
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged

Substances

  • Glial Fibrillary Acidic Protein
  • Methylprednisolone